Valneva SE (VALN)
5.16
-0.10
(-1.90%)
USD |
NASDAQ |
Jun 11, 14:10
Valneva Total Assets (Quarterly) : 428.63M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 428.63M |
| December 31, 2025 | 468.41M |
| September 30, 2025 | 526.67M |
| June 30, 2025 | 554.79M |
| March 31, 2025 | 520.92M |
| December 31, 2024 | 527.88M |
| September 30, 2024 | 576.57M |
| June 30, 2024 | 500.05M |
| March 31, 2024 | 543.06M |
| December 31, 2023 | 518.51M |
| September 30, 2023 | 551.12M |
| June 30, 2023 | 591.94M |
| March 31, 2023 | 641.01M |
| December 31, 2022 | 675.14M |
| September 30, 2022 | 683.88M |
| June 30, 2022 | 758.06M |
| March 31, 2022 | 865.32M |
| December 31, 2021 | 939.37M |
| September 30, 2021 | |
| June 30, 2021 | 883.62M |
| March 31, 2021 | 674.75M |
| December 31, 2020 | 562.62M |
| September 30, 2020 | 527.91M |
| June 30, 2020 | 437.30M |
| March 31, 2020 | 303.47M |
| Date | Value |
|---|---|
| December 31, 2019 | 307.73M |
| September 30, 2019 | 273.26M |
| June 30, 2019 | 283.72M |
| March 31, 2019 | 273.69M |
| December 31, 2018 | 274.16M |
| September 30, 2018 | 203.66M |
| June 30, 2018 | 211.88M |
| March 31, 2018 | 229.37M |
| December 31, 2017 | 227.36M |
| September 30, 2017 | 226.66M |
| June 30, 2017 | 226.06M |
| March 31, 2017 | 212.38M |
| December 31, 2016 | 218.21M |
| September 30, 2016 | 228.09M |
| June 30, 2016 | 233.06M |
| March 31, 2016 | 281.87M |
| December 31, 2015 | 298.94M |
| September 30, 2015 | 306.20M |
| June 30, 2015 | 315.41M |
| March 31, 2015 | 312.14M |
| December 31, 2014 | 275.31M |
| September 30, 2014 | 303.68M |
| June 30, 2014 | 333.23M |
| March 31, 2014 | 332.56M |
| December 31, 2013 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 207.62B |
| Nicox SA | -- |
| DBV Technologies SA | 266.40M |
| Cellectis SA | 289.19M |
| Inventiva SA | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 340.26M |
| Shareholders Equity (Quarterly) | 88.37M |
| Debt to Equity Ratio | 2.732 |
| Current Ratio | 2.138 |
| Net Debt Paydown Yield | -0.65% |